Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adly Yacoub

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cancer Research|May 31, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cellsM Danielle Bareford, Margaret A Park, Adly Yacoub, et al.
Cancer Research|May 27, 2010
Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineRupesh Dash, Joanna E Richards, Zhao-Zhong Su, et al.
Molecular Cancer Therapeutics|May 7, 2009
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanismMargaret A Park, Teneille Walker, Aditi Pandya Martin, et al.
Molecular Pharmacology|January 10, 2008
OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cellsMargaret A Park, Adly Yacoub, Mohammed Rahmani, et al.
Cancer Biology & Therapy|June 16, 2004
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cellsAdly Yacoub, Clint Mitchell, Young Hong, et al.
Molecular Cancer Therapeutics|February 19, 2008
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsAdly Yacoub, Margaret A Park, Pankaj Gupta, et al.
Anti-Cancer Drugs|July 9, 2010
MDA-7/IL-24 as a cancer therapeutic: from bench to bedsidePaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Cytokine & Growth Factor Reviews|October 8, 2010
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicityRupesh Dash, Sujit K Bhutia, Belal Azab, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer Research|May 31, 2011
Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cellsM Danielle Bareford, Margaret A Park, Adly Yacoub, et al.
Cancer Research|May 27, 2010
Mechanism by which Mcl-1 regulates cancer-specific apoptosis triggered by mda-7/IL-24, an IL-10-related cytokineRupesh Dash, Joanna E Richards, Zhao-Zhong Su, et al.
Molecular Cancer Therapeutics|May 7, 2009
MDA-7/IL-24-induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK-dependent mechanismMargaret A Park, Teneille Walker, Aditi Pandya Martin, et al.
Molecular Pharmacology|January 10, 2008
OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cellsMargaret A Park, Adly Yacoub, Mohammed Rahmani, et al.
Cancer Biology & Therapy|June 16, 2004
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cellsAdly Yacoub, Clint Mitchell, Young Hong, et al.
Molecular Cancer Therapeutics|February 19, 2008
Caspase-, cathepsin-, and PERK-dependent regulation of MDA-7/IL-24-induced cell killing in primary human glioma cellsAdly Yacoub, Margaret A Park, Pankaj Gupta, et al.
Anti-Cancer Drugs|July 9, 2010
MDA-7/IL-24 as a cancer therapeutic: from bench to bedsidePaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
Cytokine & Growth Factor Reviews|October 8, 2010
mda-7/IL-24: a unique member of the IL-10 gene family promoting cancer-targeted toxicityRupesh Dash, Sujit K Bhutia, Belal Azab, et al.
International Journal of Oncology|October 4, 2007
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review)Irina V Lebedeva, Luni Emdad, Zao-Zhong Su, et al.
Pageof 8